This page shows the latest treatment access news and features for those working in and with pharma, biotech and healthcare.
Novartis Gene Therapies and NHS England have reached a ‘landmark’ deal for Zolgensma gene therapy that gives patients with spinal muscular atrophy (SMA) access to the innovative treatment. . ... The managed access agreement for Spinraza that was
diagnosis and treatment of rare diseases. ... Improved access to specialist care, treatment and drugs for rare diseases.
It is still too early to assess the full impact of the COVID-19 pandemic on both cancer treatment and development, according to GlobalData. ... In the long term, the pandemic may have a number of far-reaching consequences on the cancer treatment
In particular, we would like to recognise the efforts of NHS England who have consistently supported appropriate access for this treatment. ... The result underscores our commitment to the colorectal cancer community and we hope that as many people as
If granted, EUA would give approval for use in severely ill patients with no other treatment options. ... The EUA application covers the same type of patients whom FDA has already allowed to receive treatment under the Expanded Access protocol authorised
COVID-19 who experience cardiovascular and other complications of multisystem inflammatory syndrome, thanks to the new expanded access protocol. ... Expanded access is a potential pathway for patients who have an immediate, life-threatening condition to
More from news
Approximately 1 fully matching, plus 221 partially matching documents found.
by Leigh Ansell. Patient support programmes (PSPs) provide help, information and advice to patients, from diagnosis through treatment. ... They get involved with patient organisations, from fundraising and events to advocacy for research funding and
The cross-collaboration has also brought forward fundamental changes and breakthroughs for the treatment of many rare genetic diseases. ... We’re looking at digital advances that would improve access to treatment and the overall patient experience.
The issue may be as simple as not being able to access their physician/GP in the usual manner, not having the usual access to their medications as regularly (if at ... Patients are also worried about access to care or treatment; the difficulties of
It will take multiple evolutions before we get an AD treatment equivalent to today’s smartphones. ... Yet a product only succeeds if patients can access it, and smooth market entry in AD.
relevance. 2. Less white space product differentiation. In crowded disease areas where compounds may show only incremental benefit, payers often make cross-product comparisons, differentiating and restricting treatment access. ... tactics for bolder
More from intelligence
Approximately 1 fully matching, plus 53 partially matching documents found.
Ugandan national Wandira-Kazibwe replaces Asha-Rose Migiro as the UN's lead advocate to end HIV-related stigma, improve access to treatment and improve national public health systems.
access to this crucial treatment to as many patients as possible.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
For those living with it, navigating a complex treatment pathway, with limited access to specialist dermatologists[ii] and whilst managing flare-ups, are significant challenges to achieving long-term goals. ... Activating people living with psoriasis to
Access to care and treatment. Access to research. Financial burden. Despite scientific development, greater healthcare awareness and technological advancements, time to diagnosis remains a significant challenge for people living with rare
As a result, it’s very likely that only wealthier people from urban areas will begin their treatment journey at these larger research institutions with the proper resources for and access ... Ninlaro is an oral treatment for multiple myeloma indicated
Ensuring market access for biobetters. Biobetters provide stepped up value to patients, such as increased convenience and further treatment options should disease progression occur. ... To achieve this, biobetters must address an unmet patient need or
Providing a trusted learning environment, with convenient access to content that supports HCP treatment decisions and patient outcomes, Medthority is funded through pharmaceutical educational grants and sponsorship. ... Optimise content for
More from PMHub
Approximately 0 fully matching, plus 30 partially matching documents found.
We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...